567-Patient Study Confirms LMWH Safety in Pregnancy
Flora Peyvandi, former President of ISTH, recently shared an insightful post on X:
”The Risk of Bleeding in Pregnant Women with Acute Venous Thromboembolism Treated with Anticoagulants: An International Multi-Database Cohort Study.”
Read the full article here.
An article ”The Risk of Bleeding in Pregnant Women with Acute Venous Thromboembolism Treated with Anticoagulants: An International Multi-Database Cohort Study”, published by Camille Simard et al. in the Journal of Thrombosis and Haemostasis, sheds light on the safety use of low-molecular-weight heparin (LMWH) in pregnancy complicated by acute venous throembolism.
This multinational (Germany;Quebec) cohort study of 567 pregnant women with VTE treated with LMWH provided new data on bleeding risk during pregnancy.
The findings suggest that LMWH type and dosing frequency may not significantly impact bleeding risk, though further research is needed to refine anticoagulation strategies for optimizing maternal outcomes.
More on scientific advancements in the field of thrombosis featured in Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis